Holen Sie sich die Stockscreener-App
80.05
0.02%
0.02
Handel nachbörslich:
80.05
Schlusskurs vom Vortag:
$80.03
Offen:
$79.43
24-Stunden-Volumen:
1.04M
Relative Volume:
0.99
Marktkapitalisierung:
$13.88B
Einnahmen:
$8.31B
Nettoeinkommen (Verlust:
$379.00M
KGV:
37.06
EPS:
2.16
Netto-Cashflow:
$385.00M
1W Leistung:
-4.97%
1M Leistung:
-3.53%
6M Leistung:
+8.07%
1J Leistung:
+14.05%
1-Tages-Spanne:
$79.43
$80.68
1-Wochen-Bereich:
$79.43
$86.36
52-Wochen-Spanne:
$60.70
$88.20
Solventum Corp Stock (SOLV) Company Profile
Firmenname
Solventum Corp
Sektor
Telefon
651-733-1110
Adresse
C/O 3M COMPANY, ST. PAUL
Vergleichen Sie SOLV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
80.05 | 13.88B | 8.31B | 379.00M | 385.00M | 2.16 |
|
ISRG
Intuitive Surgical Inc
|
546.76 | 199.16B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
207.42 | 57.41B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
80.11 | 38.80B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
259.51 | 37.17B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
43.41 | 33.73B | 27.43B | 1.27B | 1.01B | 1.5829 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-02 | Hochstufung | BTIG Research | Neutral → Buy |
| 2025-10-01 | Eingeleitet | UBS | Neutral |
| 2025-09-11 | Eingeleitet | Jefferies | Hold |
| 2025-07-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-07-01 | Hochstufung | Argus | Hold → Buy |
| 2025-06-06 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2025-05-19 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-10-08 | Eingeleitet | Stifel | Buy |
| 2024-10-07 | Eingeleitet | Piper Sandler | Neutral |
| 2024-09-26 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-09-05 | Eingeleitet | BTIG Research | Neutral |
| 2024-06-24 | Eingeleitet | Argus | Hold |
| 2024-05-30 | Eingeleitet | Goldman | Sell |
| 2024-05-10 | Eingeleitet | BofA Securities | Neutral |
| 2024-04-10 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-04-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-04-02 | Eingeleitet | Edward Jones | Hold |
Alle ansehen
Solventum Corp Aktie (SOLV) Neueste Nachrichten
Solventum (SOLV): The 3M Spin-Off That Found Its Rhythm – A 2026 Deep-Dive Analysis - FinancialContent
What is the cash position of Solventum CorporationAnalyst Upgrade & AI Powered Market Trend Analysis - bollywoodhelpline.com
Solventum Corp. stock falls Tuesday, underperforms market - MSN
Thermo Fisher Strikes Deal for Solventum’s Filtration Unit - MSN
Solventum (NYSE:SOLV) Trading Down 6.7%Here's What Happened - MarketBeat
3 Reasons SOLV is Risky and 1 Stock to Buy Instead - Finviz
Institutional investors control 73% of Solventum Corporation (NYSE:SOLV) and were rewarded last week after stock increased 9.0% - simplywall.st
Solventum Simplifies Dental Care with Advanced Fluoride Innovation - MSN
Will Solventum Corporation stock gain from strong economy2025 Fundamental Recap & Weekly Sector Rotation Insights - ulpravda.ru
Why Solventum Corporation (KB7) stock signals breakout potential2025 Macro Impact & Fast Moving Trade Plans - ulpravda.ru
Market Moves: Can Solventum Corporation stock retain market dominanceJuly 2025 Catalysts & Safe Entry Zone Tips - ulpravda.ru
Is Solventum Corporation (KB7) stock considered safe haven2025 Price Targets & Fast Entry Momentum Trade Alerts - ulpravda.ru
Assessing Solventum: Insights From 4 Financial Analysts - Benzinga
SOLV Stock: Stifel Raises Price Target to $105, Maintains Buy Ra - GuruFocus
Solventum stock price target raised to $105 from $88 at Stifel By Investing.com - Investing.com South Africa
Solventum stock price target raised to $105 from $88 at Stifel - Investing.com Australia
Is Solventum stock outperforming the Nasdaq? - MSN
Solventum Corp. stock rises Tuesday, outperforms market - MarketWatch
Solventum Corp. stock rises Monday, outperforms market - MarketWatch
AI @ HLTH: Inside Solventum’s AI Healthcare Strategy - HLTH
Solventum Advances Orthodontic Treatment by Helping Shape Modern Orthodontics - Digital Journal
Bioprocess Filtration Global Markets Report 2025-2030, Profiles of Leading PlayersDanaher, Merck, Sartorius, Solventum, and RepligenResearchAndMarkets.com - Business Wire
Solventum Corp. stock falls Wednesday, underperforms market - MarketWatch
Solventum to Acquire Acera Surgical in $725 Mn Deal to Boost Regenerative Wound-Care Portfolio - Digital Health News
Key sale, acquisition helped 3M spinoff, Solventum, turn around in 2025 - Star Tribune
Are Medical Stocks Lagging Solventum Corporation (SOLV) This Year? - Yahoo Finance
Harbor Capital Advisors Inc. Has $1.31 Million Stake in Solventum Corporation $SOLV - MarketBeat
Solventum Corporation (NYSE:SOLV) Given Consensus Rating of "Hold" by Analysts - MarketBeat
SOLV Acquires Acera Surgical to Expand Advanced Wound Care Portfolio - sharewise.com
Strong Tower Advisory Services Buys 16,851 Shares of Solventum Corporation $SOLV - MarketBeat
Solventum Completes Acquisition of Acera Surgical - The Malaysian Reserve
Solventum completes acquisition of Acera Surgical for $725 million By Investing.com - Investing.com Nigeria
Solventum Closes Acquisition of Acera Surgical - marketscreener.com
Solventum completes Acera Surgical acquisition - MassDevice
Solventum completes acquisition of Acera Surgical for $725 million - Investing.com India
Solventum is the top performing healthcare supplies stock YTD - MSN
Solventum is the top performing healthcare supplies stock YTD (SOLV:NYSE) - Seeking Alpha
How Investors Are Reacting To Solventum (SOLV) Expert Guidance Expanding Use Of Prevena ciNPT Dressings - simplywall.st
Wedge Capital Management L L P NC Sells 64,461 Shares of Solventum Corporation $SOLV - MarketBeat
Will Expert Backing for ciNPT Prevena Dressings Redefine Solventum's (SOLV) Advanced Wound Care Edge? - Yahoo Finance
Why retail investors pile into Solventum Corporation stock2025 Top Decliners & Stepwise Swing Trade Plans - Улправда
Is Solventum Stock Underperforming the S&P 500? - MSN
Solventum (SOLV): Assessing Valuation After New Clinical Guidance Expands Prevena Therapy’s Surgical Use - simplywall.st
Finanzdaten der Solventum Corp-Aktie (SOLV)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.57%
0.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):